ELCC 2017

Geneva bannerEvent Date: 15 April

The 2017 European Lung Cancer Conference (ELCC) will take place on 5–7 May 2017 at the Palaexpo Exhibition Centre, Geneva, Switzerland.

Boehringer Ingelheim will host a satellite symposium entitled ‘Sharing our knowledge in NSCLC: case interchange of real-world experience’, which will be held on Sunday 7 May 2017, 13:00–14:00 in Room C. The event will be chaired by Prof. Rolf Stahel, and will include presentations from Dr Noemí Reguart, Prof. David Gandara and Dr Maximilian Hochmair.

In addition to the symposium, there will be an oral presentation on a potential new treatment option for patients with EGFRm+ NSCLC and acquired resistance to other therapies or with pretreated advanced squamous NSCLC. There will also be four posters and two poster discussion sessions, please see below for further details.

The full ELCC 2017 programme can be found here.

Sharing our knowledge in NSCLC: case interchange of real-world experience

Sunday 7 May 2017, 13:00–14:00

Room C, Palexpo Exhibition Centre

Geneva, Switzerland

Chairperson

Chairperson
Prof. Rolf Stahel
University Hospital Zürich
Zürich
Switzerland

Speakers

Speaker
Dr Noemí Reguart
Hospital Clinic Barcelona
Barcelona
Spain
Speaker
Prof. David Gandara
University of California, Davis
Sacramento
USA
Speaker
Dr Maximilian Hochmair
Otto-Wagner-Spital
Vienna
Austria

AGENDA

13:00 – 13:05

Welcome and general introduction

Rolf Stahel

13:05 – 13:25

Making the first decision: EGFR mutation-positive NSCLC in the advanced setting

Including Q&A

Noemí Reguart

13:25 – 13:40

Understanding choice in the treatment of squamous NSCLC: when should TKIs be considered?

Including Q&A

David Gandara

13:40 – 13:55

Antiangiogenic agents beyond first-line: matching patients with treatments

Including Q&A

Maximilian Hochmair

13:55 - 14:00

Meeting close

Rolf Stahel

Click here to view the invitation

Präsentationen
X